Conditions A-Z

Glossary of conditions and symptoms linked to the study of Medicinal Cannabis

Call Today - +34 630 109 176

Glossary of Conditions and Symptoms Associated with the Use of Medicinal Cannabis

In this section we present a list where the different ailments or symptoms are present and where information on medical or scientific research on Medicinal Cannabis is available.

We are constantly expanding this list, so it may be relevant for you to visit it regularly. If you are looking for information on a particular topic and cannot find it in this section, please contact us so that we can provide you with relevant and up-to-date information on the use of Medicinal Cannabis.



The endocannabinoid system (ECS), which regulates various physiological processes, includes cell growth. The skin has numerous cananbinoid receptors, also in the sebaceous glands. Read More


The anxiolytic properties of CBD allow it to be a palliative for withdrawal symptoms. Read More


Medical cannabis seems to have a different effect on people with ADHD than on people who are not affected by the disorder. Read More


Research on CBD and Alzheimer’s has focused on the fact that CBD could promote neurogenesis, as well as significantly reduce the effect on neuronal damage. Read More

Amyotrophic Lateral Sclerosis (ALS)

Research showed that CBD slowed the progression of the disease. Read More


The influence of the CB1 and CB2 cannabinoid receptors is one of the avenues of research being pursued into the use of THC and other synthetic cannabinoids to prevent weight loss. Read More


Studies have shown that cannabis varieties concentrated in CBD (cannabidiol) would be more effective in reducing anxiety. Read More


Research has focused on the involvement of cannabinoids in inflammatory processes. It is possible that activation of the CB2 receptor has an anti-inflammatory effect. Read More


There is considerable evidence that medical cannabis can help in the treatment of ASD symptoms. Extracts rich in CBD have shown particularly positive results. Read More

Bipolar disorder

The (few) investigations so far suggest that cannabinoids do not have a sufficient spectrum of action in a manic episode. It remains clear whether CM is a valid option. Read More

Brain Traumas

Research has shown that they protect neurons from a variety of abuse believed to cause delayed neuronal death in some types of traumatic brain injury. Read More

Breast Cancer

Scientists are studying the potential of cannabinoids, not only as palliative agents, but also as anti-tumour drugs. Read More


Clinical trials carried out for other pathologies have shown the effectiveness of cannabinoids in improving lack of appetite and weight gain. Read More


There are cannabioids such as THC and CBD which are believed to have anti-tumour properties. Cannabinoids activate the CB1 and CB2 receptors and initiate cancer cell apoptosis. Read More

Chronic Pain

Chronic pain is characterised by a duration of more than 3-6 months, it can persist even if the cause has disappeared. Read More

Crohn’s disease

Several clinical trials have shown that cannabinoids can act through the CB2 receptor, reducing associated inflammation. Read More

Cystic Fibrosis

The potential of CBD is being investigated for its anti-inflammatory effect and to help reduce inflammation in the lungs or digestive tract. Read More


Within the clinical trials currently underway, the link between CBD and increased levels of anandamide is being sought in order to have an antidepressant effect. Read More


A study focusing on tetrahydrocannabivarin ( THCV) showed that it can be a potential agent for glycaemic control in diabetics. Read More

Dravet Syndrome

The monthly frequency of seizures was reduced by 38-44% in the case of seizures and 39-51% in the case of CBD seizures. Read More


A medical paper found that the use of Cannabidiol showed a favourable dose-response relationship to decrease in dyskinesias, tics and dystonia. Read More

Ehlers-Danlos syndrome

Observing some specific symptoms, CBD could be an excellent prescription due to its analgesic, anxiolytic and anti-inflammatory actions. Read More


The anti-inflammatory and analgesic effect of phytocannabinoids allows an improvement in the symptoms of endometriosis. Read More

Epidermolysis Bullosa

Research on patients with epidermolysis bullosa is showing the potential of cannabinoids to inhibit the proliferation of dangerous epidermal cells. Read More


Studies suggest that cannabinoids as an adjuvant treatment for seizures can reduce them by a large percentage. Read More


Results from studies suggest that cannabinoids may offer some benefit as a treatment for the pain suffered by people with fibromyalgia. Read More


Research from 2018 has shown that ESA can not only reduce eye pressure, but can also act on certain receptors to act as neuroprotectors against damage to the optic nerve. Read More


One study found that cananbinoids interact with the CB1 receptors, those that play an important role in analgesia, and their activation significantly reduces pain. Read More

Hepatitis C

There is conflicting research on the use of cannabinoids. And further studies are pending to determine their effectiveness. Read More


CB2 agonist receptors reduce the mechanisms of HIV infection. However, several studies are needed to better understand the medical potential of cannabis to treat HIV and AIDS. Read More

Hypoxic ischemic encephalopathy (HIE)

Spanish researchers investigate the CBD for HIE. With a clinical trial in Spanish and British hospitals, we have relevant data. Read More


Results from studies suggest that cannabinoids may offer some benefit as a treatment for the pain suffered by people with fibromyalgia. Although CBD and THC are almost identical molecules, CBD’s properties make it a powerful antioxidant. Read More

Inflammatory Bowel Diseases (IBD)

The analgesic and anti-inflammatory effect of cannabinoids improve the symptoms of patients with inflammatory bowel diseases. Read More


The effect of cannabinoids is notorious for their relaxing and “sleeping” effect without affecting the cognitive state or becoming addictive after intake. Read More

Irritable Bowel Syndrome (IBS)

Endocannabinoids may represent the most promising therapeutic neuromodulatory target. Read More

Lung Cancer

In studies from 2019 it was found that THC, CBD and CBN cananbinoids could inhibit the growth of bronchial carcinoma. Read More


When CBD is given in the right dose, it can help to relieve pain. This has been confirmed in several studies on neuropathic pain and cancer pain. Read More

Multiple Sclerosis

The effect of cannabinoids is notorious for the decrease in spasms and cramps. Read More


There is much research that has studied the effect of cannabinoids on menopausal symptoms such as pain, mood swings and sleep problems. Read More


The researchers explained that medicinal cannabis could be an alternative therapy for the prevention of migraines. Read More


THC and CBD not only reduce nausea and vomiting caused by antineoplastic agents, but also increase appetite, sleep habits and relieve pain.  Read More


In light of the current data available, blocking CB1 by using its antagonists may be an efficient way to address obesity. Read More

Lennox Gastaut Syndrome

Although so far it can only be claimed that CBD is the cannabinoid with the most properties for treating Lennox-Gastaut syndrome, it is believed that if other cannabinoids worked with it, the entourage effect could be achieved. Read More


Cannabinoid-based medicines in their application to tissue engineering, aimed at mitigating the degradation of cartilage and facilitating its repair. Read More


The analgesic effect of cannabinoids is one of the best characterised effects. Cannabinoids may offer some benefit as a treatment for chronic pain. Read More


The researchers noted that among THC-positive patients, their acute pancreatitis was much less severe and much less painful than that of patients who had not used cannabis. Read More


Several studies have shown that CBD can reduce symptoms such as restlessness, tremors, sleep disorders and anxiety. Read More

Post Traumatic stress disorder (PTSD)

Further research into the molecular interaction of post-traumatic stress disorder and the endocannabinoid system may increase the potential for effective treatments. Read More


A multicentre randomised controlled trial suggests that CBD may present a new class of treatment for this disorder. However, more research is needed. Read More


Several studies on medicinal cannabis have demonstrated the effectiveness of CB1R cannabinoid receptors in relieving the symptoms caused by inflammatory skin diseases. Read More

Refractory Epilepsy

The anticonvulsant effect in the different international trials indicates that in a percentage of people with refractory epilepsy events are significantly reduced. Read More

Refractory Obsessive Compulsive Disorder (OCD)

Overall, these studies demonstrated a therapeutic potential for cannabinoids to reduce obsessive-compulsive disorders.  Read More

Restless Legs Syndrome

Based on widespread information about the medical benefits of cannabinoids, more pre-clinical and clinical studies are needed. Read More

Tourette’s syndrome

Cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) have the potential to improve the symptoms of Tourette syndrome and the quality of life of those affected without being burdened by serious side effects. Read More

Sleep Apnoea

Research has shown positive results with THC in sleep apnoea: breathing interruptions were reduced and daytime fatigue decreased. Read More

Sleep disorders

Research on the two main cannabinoids of the cannabis plant, CBD and THC, has shown different efficacy depending on the form of administration, dose and frequency. Read More

Ulcerative Colitis

Research has focused on the use of CBD for its analgesic and anti-inflammatory effect, as it improves the stimulation of the neuroimmune axis. Read More